Moreover, the expression levels of RERE-AS1 (p < 0.05), TFAP2A-AS1 (p < 0.01), and MIR302CHG (p < 0.05) varied according to tumor stage (stage I, II, III, and IV), COL4A2-AS1, RERE-AS1, NDUFA6-DT, and MIR302CHG varied according to T stage (T1, T2, T3, and T4). The gene discussed is TFAP2A; the disease is neoplasm.